Search results
Hypertension 2020
Start date:
Sep 10, 2020
End date:
Sep 13, 2020
Event
Pulmonary Hypertension
Added:
3 years ago
Article
Hypertension Summit 2015
Start date:
Oct 06, 2015
End date:
Oct 08, 2015
Event
Added:
3 years ago
A not inconsequential number of therapeutic agents or chemical substances can increase blood pressure (BP). The degree to which BP increases determines whether a specific definitional threshold has been crossed, at which time the patient is designated as having become hypertensive. Drugs that cause hypertension do so by either causing vasoconstriction, increasing extracellular fluid (ECF) volume,…
View more
Start date:
Feb 20, 2014
End date:
Feb 22, 2014
Resistant Hypertension Course
Novel approaches for management of a patient presenting with Resistant Hypertension
View more
Start date:
Sep 06, 2018
End date:
Sep 09, 2018
Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities. With experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity, and genetics, attendees will…
View more
Added:
3 years ago
Chronic thromboembolic pulmonary hypertension (CTEPH) results from obstruction of the major pulmonary arteries by unresolved or organized pulmonary emboli that have become incorporated into the vessel wall, ultimately causing increased pulmonary vascular resistances. Without intervention, CTEPH is a progressive, fatal disease for which there is no proven effective medical therapy. Pulmonary…
View more
Added:
3 years ago
The lower level to which blood pressure should be taken and how soon treatment should be started are key considerations where aging and cardiovascular mortality risks are concerned. It has long been taught that blood pressure should be allowed to rise to a level deemed pre-hypertensive or hypertensive before non-pharmacological and pharmacological therapy is embarked upon. Is this really the…
View more
Added:
3 years ago
There has been an increase in the prevalence of diabetes mellitus over the past 40 years, both in the US and worldwide. The worldwide prevalence of diabetes in 2000 was approximately 2.8% and is estimated to grow to 4.4% by 2030. This translates to a projected rise of diabetes from 171 million in 2000 to well over 350 million in 2030. The epidemic of diabetes will continue to rise as there is…
View more
Start date:
Jun 27, 2014
End date:
Jun 29, 2014
Gaps in the level of Hemoglobin A1C, BP, and LDL-Cholesterol reduction continue to occur in high-risk individuals with Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Recent results from the ACCORD, VADT, and ADVANCE studies suggest the benefits on reducing macrovascular disease events are unclear and, in fact, caution should be exercised when reducing Hemoglobin A1C in those with…
View more
